Development of a green fluorescent protein metastatic-cancer chick-embryo drug-screen model

Clinical and Experimental Metastasis

Volumn 21, Issue 4, 2004, Pages 347-352

  Bobek, Vladimir ^a   Plachy, Jiri ^b   Pinterova, Daniela ^a   Kolostova, Katarina ^a   Boubelik, Michael ^b   Jiang, Ping ^c   Yang, Meng ^c   Hoffman, Robert M ^c  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

^c ANTICANCER INC   (United States)

Author keywords

chick embryo; gemcitabine; green fluorescent protein; Lewis lung carcinoma; metastasis; streptokinase

Indexed keywords

GEMCITABINE; GREEN FLUORESCENT PROTEIN; STREPTOKINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CARCINOMA CELL; CHICK EMBRYO; CONTROLLED STUDY; DOSE RESPONSE; EMBRYO; EMBRYO DEVELOPMENT; FLUORESCENCE; HEART; INCUBATION TIME; LEWIS CARCINOMA; METASTASIS; NONHUMAN; PROTEIN EXPRESSION; STERNUM;

ANIMALS; CARCINOMA, LEWIS LUNG; CHICK EMBRYO; DEOXYCYTIDINE; DISEASE MODELS, ANIMAL; DRUG SCREENING ASSAYS, ANTITUMOR; GREEN FLUORESCENT PROTEINS; MICE; MICE, INBRED C57BL; NEOPLASM METASTASIS; STREPTOKINASE;

EID: 7244232892     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:CLIN.0000046138.58210.31     Document Type: Article

References (34)

1. Cuadra M. Chorio-allantoic membrane touch preparations. Anat Record 1964; 149: 425-41.
2. Murphy JB. Transplantability of malignant tumors to embryos of a foreign species. J Am Med Assoc 1912; 59: 874.
3. Leighton, Joseph. The Spread of Cancer. Pathogenesis, Experimental Methods, Interpretations. Chapter VII: The Spread of Cancer Explored in the Embryonated Egg. New York: Academic Press 1967; 115-92.
4. Alfthan OS. A comparative study of the growth of skin and human skin tumors on the chorioallantoic membrane of the embryonated chicken eggs. Ann Med Exp Biol Fenniae (Helsinki) 1956; 34 (Suppl 9): 1-97.
5. Dagg CP, Karnofsky DA, Toolan HW, Roddy J. Serial passage of human tumors in chick embryo: Growth inhibition by nitrogen mustard. Proc Soc Exp Biol Med 1954; 87: 223-7.
6. Levi-Montalcini R. Growth control of nerve cells by a protein factor and its antiserum. Science 1964; 143: 105-10.
7. Bender DH, Friedgood CE, Lee HF. Transplantation of heterologous tumors by the intravenous inoculation of the chick embryo. Cancer Res 1949; 9: 61-4.
8. Karnofsky DA, Dagg CP, Ortega LG et al. Metastases from mouse tumors growing on the chorioallantoic membrane of the chick embryo. Proc Am Assoc Cancer Res 1957; 2: 220-1.
9. Chambers AF, Schmidt EE, MacDonald IC et al. Early steps in hematogenous metastasis of B16F1 melanoma cells in chick embryos studied by high-resolution intravital videomicroscopy. J Natl Cancer Inst 1992; 84: 797-803.
10. Morris VL, Koop S, MacDonald IC et al. Mammary carcinoma cell lines of high and low metastatic potential differ not in extravasation but in subsequent migration and growth. Clin Exp Metast 1994; 12: 357-67.
11. Hoffman RM. Green fluorescent protein imaging of tumour growth, metastasis, and angiogenesis in mouse models. Lancet Oncol 2002; 3: 546-56.
12. Rashidi B, Yang M, Jiang P et al. A highly metastatic Lewis lung carcinoma orthotopic green fluorescent protein model. Clin Exp Metast 2000; 18: 57-60.
13. Vainio O. Experimental immunology in chicken. In Lefkovits I (ed): Immunology Methods Manual. 2185-97. San Diego: Academic Press 1997; 2185-97.
14. van Moorsel CJA, Pinedo HM, Veerman G, Vermorken JB, Postmus PE, Peters GJ. Scheduling of gemcitabine and cisplatin in Lewis lung tumor bearing mice. Eur J Cancer 1999; 35: 808-14.
15. Malke H, Roe B, Ferretti JJ. Nucleotide sequence of the streptokinase gene from Streptococcus equisimilis H46A. Gene 1985; 34: 357-62.
16. Christensen LR. Streptococcal fibrinolysis: A proteolytic reaction due to a serum enzyme activated by streptococcal fibrinolysin. J Gen Physiol 1945; 28: 363-83.
17. Palumbo JS, Kombrinck KW, Drew AF et al. Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. Blood 2000; 96: 3302-9.
18. Arkel YS. Thrombosis and cancer. Semin Oncol 2000; 27: 362-74.
19. Francis JL, Biggerstaff J, Amirkhosravi A et al. Hemostasis and malignancy. Semin Thromb Haemost 1998; 24: 93-109.
20. Burris HA 3rd, Moore MC, Anderson J et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial. J Clin Oncol 1997; 15: 2403-13.
21. Katagiri Y Hiroyama T, Akamatsu N, et al. Involvement of alpha v beta 3 integrin in mediating fibrin gel reaction. J Biol Chem 1995; 270: 1785-90.
22. Suehiro K, Gailit J, Plow EF. Fibrinogen is a ligand for integrin alpha5beta1 on endothelial cells. J Biol Chem 1997; 272: 5360-6.
23. Farrell DH, al-Mondhiry HA. Human fibroblast adhesion to fibrinogen. Biochemistry 1997; 36: 1123-8.
24. Greenberg CS, Dobson JV, Miraglia CC. Regulation of plasma factor XIII binding to fibrin in vitro. Blood 1985; 66: 1028-34.
25. Engvall E, Ruoslahti E, Miller EJ. Affinity of fibronectin to collagens of different genetic types and to fibrinogen. J Exp Med 1978; 147: 1584-95.
26. Dvorak HF, Nagy JA, Berse B et al. Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation. Ann N Y Acad Sci 1992; 667: 101-11.
27. Skogen WF, Senior RM, Griffin GL, Wilner GD. Fibrinogen-derived peptide B beta 1-42 is a multidomained neutrophil chemoattractant. Blood 1988; 71: 1475-9.
28. Languino LR, Duperray A, Joganic KJ et al. Regulation of leukocyte-endothelium interaction and leucocyte transendothelial migration by intercellular adhesion molecule 1-fibrinogen recognition. Proc Natl Acad Sci USA 1995; 92: 1505-9.
29. Gross TJ, Leavell KJ, Peterson MW. CD11b/CD18 mediates the neutrophil chemotactic activity of fibrin degradation product D domain. Thromb Haemost 1997; 77: 894-900.
30. Daido R, Koike A, Nomiyama Y et al. Effects of selective administration of anticancer agents in massive doses combined with fibrinolytic enzyme (urokinase) in hepatic cancer. Gan No Rinsho 1972; 18: 285-9 [in Japanese].
31. Holt JAG. The extra nuclear control of mitosis and cell function. A theory of cellular organization. Med Hypotheses 1980; 6: 145-92.
32. Thornes RD. Unblocking or activation of the cellular immune mechanism by induced proteolysis in patients with cancer. Lancet 1974; 2: 382-4.
33. Meehan KR, Zacharski LR, Maurer LH et al. Studies of possible mechanisms for the effect of urokinase therapy in small cell carcinoma of the lung. Blood Coagul Fibrinol 1995; 6: 105-12.
34. Petitclerc E, Brooks PC. The chick embryo metastasis model. In Brooks, SA, Schumacher U (eds): Metastasis Research Protocols, Volume II: Analysis of Cell Behavior in vitro and in vivo. Totowa, New Jersey: Humana Press, 2001; 173-177.